Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
with clinicians, neuroscientists, and molecular biologists to interpret AI-based findings and translate models into clinically actionable tools for early diagnosis, risk prediction, and patient
-
and refine the RG-based model to enhance its biological interpretability and robustness across different tumor types; to extend the model to simulate and predict solid tumor response to innovative